SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?


To: Jeffrey S. Mitchell who wrote (3225)8/20/1998 11:00:00 AM
From: Graham Marshman  Respond to of 4028
 
Haven't seen that much switching in the technology base, just in its application. Yes, the pregnancy suspension was a total failure and abandoned. That happens.

Since then their core technology has always been vector delivery of ssDNA. Primary application initially was telomere repair - this is now delayed behind antisense molecule delivery, but it's all built on the same core technology. Incidentally, I totally believe in a significant future for both gene therapy and antisense - they both have their merits.

Other businesses mentioned ie shrimp, regeniderm have all been tactical approaches to near term revenues. Not a bad thing, in fact good if they can be achieved without defocusing the main event.

Yes there's lots of vectors out there, but CYGS claims the only one capable of delivering ssDNA into the cell. Not insignificant in my view. This should be publishable in its own right.

Yes, there's a long road ahead to a cure, but I like early stage biomeds. Lots of opportunity for market cap increase ahead of realizing product revenues. Much less risk than later stage companies in my experience. I prefer this to binary crash or explode action based on the results of a Phase III trial. Alliances do happen. Also the time must be coming for big pharma to take a more active role in both gene therapy and antisense, don't you think. Lots of possibilities in my view.

I agree that if anyone's expecting a killer news item and CYGS going to $100 in the next three months with a cure for cancer, they're delusional. I do expect some solid increases in market cap over time as things unfold, but everyone needs to make up their own mind about that. It's easy, for me personally, to see increases in the current $12M cap on publication, alliances, further science announcements etc. as/when/if they happen.

You and many others don't like this early stage - fine. That's what it's all about, that's why stock prices rise.

Graham



To: Jeffrey S. Mitchell who wrote (3225)8/20/1998 11:02:00 AM
From: DavidCG  Read Replies (3) | Respond to of 4028
 
The only track record I look at is stock price action.

CYGS a few months back at .20.. today CYGS at $1.00...

Any stock which maintains not only a 100% rise but a 400% rise in price is worthy of my attention/adoration.

Even with about 7 of you folks ripping on CYGS, it still will not break the .75 barrier.

That fact is not only hillarious to me (because it seems you are just wasting your breath/time in here)...but also impressive for this stock.

I only visit this thread every week or so... but it is amazing how all this skepticism for this company still doesn't tank it to say .50

Heh.

You all may now get return to your regularly scheduled bash-fest...
I sure as heck won't stop you!

Graham... I have a theory that some of these folks are major anti-abortionist activists...thereby we keep hearing about frozen babies... I guess i never ventured that far back in CYGS's history...nor care what they did years ago. But was the proposed research on frozen fetuses?.... A fetus is different from a BABY in my eyes...but then I'm not a bomb throwing, radical, anti-abortionist.
I think this is what drives some of the people here.
Just a theory, anyway.

-DavidCG